Annovis Bio (ANVS) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ANVS is expected to report earnings to fall 66.54% to -32 cents per share on April 08

Q4'24

Est.

$-0.32

Q3'24

Missed

by $0.46

Q2'24

Beat

by $0.19

Q1'24

Beat

by $0.10

Q4'23

Missed

by $0.83

The last earnings report on November 11 showed earnings per share of -97 cents, missing the estimate of -50 cents. With 359.78K shares outstanding, the current market capitalization sits at 64.99M.

View a ticker or compare two or three

Compare

ANVS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ANVS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

101 Lindenwood Drive

Phone

+1 484 875-3192

Employees

Web

https://www.annovisbio.com